Anipamil
Alternative Names: LU 42668Latest Information Update: 24 Jan 2013
At a glance
- Originator Abbott GmbH & Co. KG
- Class Antiarrhythmics; Antihypertensives
- Mechanism of Action Calcium channel antagonists; LDL receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Atherosclerosis; Hyperlipidaemia; Hypertension; Ischaemic heart disorders
Most Recent Events
- 29 Apr 1996 Discontinued-III for Hypertension in Germany (PO)
- 29 Apr 1996 Discontinued-III for Ischaemic heart disorders (Unknown route)
- 29 Apr 1996 Discontinued-III for Ischaemic heart disorders in Uganda (Unknown route)